Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lung Diseases × Pemetrexed × Clear all

Phase

Phase 3 4 Phase 2 3 Phase 1 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Mesothelioma 3 Lung Neoplasms 2 Adenocarcinoma of Lung 2 Adenocarcinoma 2 Thoracic Neoplasms 1 Non-Small Cell Lung Cancer Metastatic 1 Lung Diseases 1 Locally Advanced Malignant Neoplasm 1 Advanced Non-squamous Non-small-cell Lung Cancer 1

Interventions

Carboplatin 2 Vinorelbine 1 Pemetrexed 1 Paclitaxel 1 One-Lung Ventilation 1 Nivolumab 1 Natriuretic Peptide, Brain 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 Anesthesia, General 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05583188 2024-07-19

VIGOR

Galvanize Therapeutics, Inc.

Phase 4 Terminated

Lung Diseases, Lung Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡